<b>Methods</b>: A 73-year-old man, who had branch retinal vein occlusion with refractory macular edema despite multiple anti-VEGF injections, received an intravitreal Ozurdex<sup>®</sup> (Allergan, Irvine, CA, USA) implant. This evidence concerns the gene VEGFA and macular retinal edema.